IL6 and breast carcinoma: A-FABP, which is highly expressed in TAMs of mouse and human breast cancer cells, enhances IL-6/STAT3 signaling by regulating the NF-κB/miR-29b pathway, thereby promoting breast cancer growth and metastasis67.